Virtual Care Rapid Scoping

Details

During the COVID-19 pandemic, the use of virtual care increased rapidly throughout the health care system in Canada as it was offered to maintain care delivery while physical distancing measures to control the spread of COVID-19 reduced in-person care. This rapid uptake highlighted different issues and uncertainties associated with delivering care virtually and the need for developing or improving approaches to guide the effective integration of virtual services within the health care delivery continuum.

An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices

Details

This report provides an overview of continuous learning artificial intelligence (AI) as a medical device or as part of a medical device, including what they are, how they might be used, their benefits, and the potential challenges and opportunities they pose for regulation, assessment, and evaluation. Continuous learning AI for health care may have a cascading effect on national and international level, including reshaping and shifting the role of regulators and health technology assessment agencies.

Enablers for Remote Monitoring Programs for Cardiac Conditions: Lessons From the COVID-19 Pandemic

Details

Key Messages

  • Throughout the COVID-19 pandemic, Canada’s health care system has experienced a dramatic shift toward virtual care. Patients with cardiac conditions are at an increased risk of adverse outcomes from COVID-19 infections, and for many, remote monitoring has been viewed as a safer form of health care delivery.
  • This Policy Insight summarizes key facilitators and barriers to the implementation and expansion of remote monitoring programs for patients with cardiac conditions based on lessons learned during the COVID-19 pandemic. These include:

2022 Health Technology Trends to Watch

Details

The Health Technology Trends to Watch list covers a range of new and emerging non-drug health technologies relevant to different conditions, models of health care delivery, and tools used to improve patient care.

This project aims to:

An Overview of Smartphone Apps

Details

Health-based mobile applications (“mHealth”) are downloadable applications on a smartphone or similar device for use in health care, either by the person directly using it or by a health care provider. This Horizon Scan summarizes the available information and provides an overview of health apps on smartphones that are not connected to specialized medical equipment, describing examples of emerging apps in different clinical areas, who they might benefit, and their operational issues.

 

Digital Pathology Using Primary Case Sign-Out

Details

Question

  1. What is the clinical utility for digital pathology using primary case sign-out?
  2. What is the diagnostic accuracy of digital pathology using primary case sign-out?
  3. What is the cost-effectiveness of digital pathology using primary case sign-out?

Key Message

The applicability of the identified findings and the potential impact on patient outcomes for any individual diagnostic setting was unclear. In the majority of the identified studies, the authors reported diagnostic accuracy and clinical utility outcomes that supported digital pathology systems as a valuable diagnostic modality, comparable to conventional microscopy. These studies lacked statistical power calculations, making the accuracy of these statements unclear. One systematic review and 1 diagnostic study reported clinical utility outcomes of digital pathology. This evidence supported digital pathology using primary case sign-out for accurate prognosis of patient outcomes; however, the clinical utility compared to conventional microscopy was unclear in the identified evidence. One systematic review and 13 diagnostic cohort studies reported on the diagnostic accuracy of whole slide image (WSI). The identified outcomes indicated that WSI is a valuable diagnostic modality; however, a large range of diagnostic accuracy in different settings, and a lack of clear statistical power in all studies make comparator conclusions to conventional microscopy unclear. One systematic review and 4 diagnostic cohort studies reported diagnostic areas that can present challenges for a digital pathology implementation, the most common being the interpretation and grading of dysplasia. One identified systematic review stressed the importance of whole-system validation to identify strengths and weaknesses of specific digital pathology implementations. The range of diagnostic accuracy across studies also indicated that implementation of digital pathology primary case sign-out systems is associated with unclear diagnostic accuracy until appropriately validated. No relevant cost-effectiveness evidence for digital pathology using primary case sign-out was identified.

Remote Substance-Monitoring Devices and Mobile Applications for Substance Use Disorders

Details

Question

  1. What is the clinical effectiveness of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders?
  2. What is the cost-effectiveness of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders?
  3. What are the evidence-based guidelines regarding the use of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders?

Key Message

One health technology assessment and 3 randomized controlled trials were identified regarding the clinical effectiveness of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders. No evidence was found regarding the cost-effectiveness of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders. No evidence-based guidelines were identified regarding the use of remote substance-monitoring devices and mobile applications for the treatment of substance use disorders.